GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications

GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a new study in Nature Communications, showcasing the company’s novel AI-based liquid biopsy technology.